Cbdmd, Inc. 8-K Filing
Ticker: YCBD · Form: 8-K · Filed: Nov 28, 2025 · CIK: 1644903
| Field | Detail |
|---|---|
| Company | Cbdmd, Inc. (YCBD) |
| Form Type | 8-K |
| Filed Date | Nov 28, 2025 |
| Pages | 7 |
| Reading Time | 8 min |
| Key Dollar Amounts | $340,000 |
| Sentiment | neutral |
Sentiment: neutral
FAQ
What type of filing is this?
This is a 8-K filing submitted by Cbdmd, Inc. (ticker: YCBD) to the SEC on Nov 28, 2025.
What are the key financial figures in this filing?
Key dollar amounts include: $340,000 (y will pay Mr. Kennedy a base salary of $340,000. The Company also granted Mr. Kennedy a).
How long is this filing?
Cbdmd, Inc.'s 8-K filing is 7 pages with approximately 2,099 words. Estimated reading time is 8 minutes.
Where can I view the full 8-K filing?
The complete filing is available on SEC EDGAR. You can also read the AI-decoded analysis with risk assessment and key highlights on ReadTheFiling.
Filing Stats: 2,099 words · 8 min read · ~7 pages · Grade level 14.8 · Accepted 2025-11-28 17:30:35
Key Financial Figures
- $340,000 — y will pay Mr. Kennedy a base salary of $340,000. The Company also granted Mr. Kennedy a
Filing Documents
- ycbd20251128_8k.htm (8-K) — 40KB
- ex_893882.htm (EX-10.1) — 95KB
- ex_893883.htm (EX-10.2) — 85KB
- cbdmd01.jpg (GRAPHIC) — 3KB
- 0001437749-25-036497.txt ( ) — 398KB
- ycbd-20251128.xsd (EX-101.SCH) — 3KB
- ycbd-20251128_def.xml (EX-101.DEF) — 11KB
- ycbd-20251128_lab.xml (EX-101.LAB) — 15KB
- ycbd-20251128_pre.xml (EX-101.PRE) — 11KB
- ycbd20251128_8k_htm.xml (XML) — 3KB
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. Exhibit Description 10.1 Executive Employment Agreement dated November 28, 2025 by and between cbdMD, Inc. and T. Ronan Kennedy 10.2 cbdMD, Inc. 2025 Equity Compensation Plan 104 Cover Page Interactive Data File (embedded within the inline XBRL document)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. cbdMD, Inc. Date: November 28, 2025 By: / s/ T. Ronan Kennedy T. Ronan Kennedy, Chief Executive Officer and Chief Financial Officer